17,20(E)-dehydro vitamin D analogs and their uses

Details for Australian Patent Application No. 2005309790 (hide)

Owner Wisconsin Alumni Research Foundation

Inventors Deluca, Hector F.; Tadi, Bulli Padmaja; Clagett-Dame Margaret; Plum, Lori,A.

Agent Pizzeys

Pub. Number AU-B-2005309790

PCT Pub. Number WO2006/057885

Priority 60/630,007 22.11.04 US

Filing date 18 November 2005

Wipo publication date 1 June 2006

Acceptance publication date 8 March 2012

International Classifications

C07C 401/00 (2006.01) Irradiation products of cholesterol or its derivatives

A61K 31/59 (2006.01) - Compounds containing 9,10-seco-cyclopenta[a]hydro- phenanthrene ring systems

A61P 11/06 (2006.01) Drugs for disorders of the respiratory system

A61P 17/06 (2006.01) Drugs for dermatological disorders

A61P 29/00 (2006.01) Non-central analgesic, antipyretic or antiinflammatory agents, e.g antirheumatic agents

A61P 35/00 (2006.01) Antineoplastic agents

A61P 37/00 (2006.01) Drugs for immunological or allergic disorders

Event Publications

14 June 2007 PCT application entered the National Phase

  PCT publication WO2006/057885 Priority application(s): WO2006/057885

8 March 2012 Application Accepted

  Published as AU-B-2005309790

5 July 2012 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2005309791-2-methylene-19,26,27-trinor-(20S)-1alp ha-alpha-hydroxyvitamin D3 and its uses

2005309789-2alpha-methyl and 2beta-methyl analogs of 19,26,27-trinor-(20S)-1alpha-hydroxyvit amin D3 and their uses